A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants
Titel:
A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants
Auteur:
Tameris, M. Hokey, D.A. Nduba, V. Sacarlal, J. Laher, F. Kiringa, G. Gondo, K. Lazarus, E.M. Gray, G.E. Nachman, S. Mahomed, H. Downing, K. Abel, B. Scriba, T.J. McClain, J.B. Pau, M.G. Hendriks, J. Dheenadhayalan, V. Ishmukhamedov, S. Luabeya, A.K.K. Geldenhuys, H. Shepherd, B. Blatner, G. Cardenas, V. Walker, R. Hanekom, W.A. Sadoff, J. Douoguih, M. Barker, L. Hatherill, M.